These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25782198)

  • 1. [Treatment of hypertension in chronic kidney disease].
    Jędras M; Sawicka M
    Wiad Lek; 2014; 67(3):402-4. PubMed ID: 25782198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New aspects of hypertension management in patients with chronic kidney disease].
    Vakilzadeh N; Phan O; Forni Ogna V; Burnier M; Wuerzner G
    Rev Med Suisse; 2014 Sep; 10(441):1668-72. PubMed ID: 25322626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arterial hypertension and proteinuria in pediatric chronic kidney disease.
    Simonetti GD; Bucher BS; Tschumi S; Lava SA; Bianchetti MG
    Minerva Pediatr; 2012 Apr; 64(2):171-82. PubMed ID: 22495191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of antihypertensive drugs on chronic kidney disease: a comprehensive review.
    Ptinopoulou AG; Pikilidou MI; Lasaridis AN
    Hypertens Res; 2013 Feb; 36(2):91-101. PubMed ID: 23051659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation and pharmacologic approach to patients with resistant hypertension.
    Adams M; Bellone JM; Wright BM; Rutecki GW
    Postgrad Med; 2012 Jan; 124(1):74-82. PubMed ID: 22314117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K
    Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of antihypertensive treatment in chronic renal failure: to what extent and with which drugs do patients treated by nephrologists achieve the recommended blood pressure?
    Giverhaug T; Falck A; Eriksen BO
    J Hum Hypertens; 2004 Sep; 18(9):649-54. PubMed ID: 15002005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
    Kujal P; Chábová VČ; Vernerová Z; Walkowska A; Kompanowska-Jezierska E; Sadowski J; Vaňourková Z; Husková Z; Opočenský M; Skaroupková P; Schejbalová S; Kramer HJ; Rakušan D; Malý J; Netuka I; Vaněčková I; Kopkan L; Cervenka L
    Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1159-69. PubMed ID: 20880190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the renin-angiotensin-aldosterone system for cerebrorenal protection.
    Lambers Heerspink HJ
    Contrib Nephrol; 2013; 179():7-14. PubMed ID: 23652444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strict blood-pressure control and progression of renal failure in children.
    ; Wühl E; Trivelli A; Picca S; Litwin M; Peco-Antic A; Zurowska A; Testa S; Jankauskiene A; Emre S; Caldas-Afonso A; Anarat A; Niaudet P; Mir S; Bakkaloglu A; Enke B; Montini G; Wingen AM; Sallay P; Jeck N; Berg U; Caliskan S; Wygoda S; Hohbach-Hohenfellner K; Dusek J; Urasinski T; Arbeiter K; Neuhaus T; Gellermann J; Drozdz D; Fischbach M; Möller K; Wigger M; Peruzzi L; Mehls O; Schaefer F
    N Engl J Med; 2009 Oct; 361(17):1639-50. PubMed ID: 19846849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk and prevention of diabetic nephropathy].
    Ravera M; Re M; Deferrari G
    G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated N-terminal pro-brain natriuretic peptide levels predict an enhanced anti-hypertensive and anti-proteinuric benefit of dietary sodium restriction and diuretics, but not angiotensin receptor blockade, in proteinuric renal patients.
    Slagman MC; Waanders F; Vogt L; Damman K; Hemmelder M; Navis G; Laverman GD
    Nephrol Dial Transplant; 2012 Mar; 27(3):983-90. PubMed ID: 21862455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of hypertension in CKD patients].
    Kusaba T; Kimura K
    Nihon Rinsho; 2008 Sep; 66(9):1747-52. PubMed ID: 18788405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contribution of diuretics to the treatment of hypertension in patients with CKD].
    Ura N; Yamaji I
    Nihon Jinzo Gakkai Shi; 2009; 51(4):446-50. PubMed ID: 19601551
    [No Abstract]   [Full Text] [Related]  

  • 18. Blood pressure in renal disease: how to accomplish the goal?
    Robles NR; Hernandez-Gallego R
    Cardiovasc Ther; 2012 Aug; 30(4):193-8. PubMed ID: 22759229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correction of aldosterone level as marker of RAAS dysfunction in patients with arterial hypertension degree II-III and chronic kidney diseases].
    Dralova OV; Maksimov ML; Derbentseva EA; Ermolaeva AS; Starodubtsev AK
    Eksp Klin Farmakol; 2011; 74(4):14-7. PubMed ID: 21678653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should diuretics always be included as initial antihypertensive management in early-stage CKD?
    Segura J; Ruilope LM
    Curr Opin Nephrol Hypertens; 2009 Sep; 18(5):392-6. PubMed ID: 19561495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.